Advertisement

Topics

Alnylam opens new European office in Maidenhead, UK

14:07 EDT 22 Sep 2016 | CentreWatch

Alnylam Pharmaceuticals, an RNAi therapeutics company, has announced the expansion of its global footprint with the opening of a new development and commercial hub in Maidenhead, U.K. In anticipation of substantial growth across Alnylam over the next five years, the office opens with a core clinical development, regulatory affairs and commercial team and space for […]

The post Alnylam opens new European office in Maidenhead, UK appeared first on CenterWatch News Online.

Original Article: Alnylam opens new European office in Maidenhead, UK

NEXT ARTICLE

More From BioPortfolio on "Alnylam opens new European office in Maidenhead, UK"

Quick Search
Advertisement